Inflammatory Bowel Disease Unit, St. Mark's Hospital, Harrow HA1 3UJ, UK.
Department of Gastroenterology, The Hillingdon Hospital, Uxbridge UB8 3NN, UK.
Nutrients. 2021 May 23;13(6):1780. doi: 10.3390/nu13061780.
The gut microbiome has been implicated in a range of diseases and there is a rapidly growing understanding of this ecosystem's importance in inflammatory bowel disease. We are yet to identify a single microbe that causes either ulcerative colitis (UC) or pouchitis, however, reduced microbiome diversity is increasingly recognised in active UC. Manipulating the gut microbiome through dietary interventions, prebiotic and probiotic compounds and faecal microbiota transplantation may expand the therapeutic landscape in UC. Specific diets, such as the Mediterranean diet or diet rich in omega-3 fatty acids, may reduce intestinal inflammation or potentially reduce the risk of incident UC. This review summarises our knowledge of gut microbiome therapies in UC and pouchitis.
肠道微生物群与一系列疾病有关,人们对其在炎症性肠病中的重要性的理解也在迅速加深。我们尚未确定任何一种微生物会导致溃疡性结肠炎(UC)或袋炎,然而,在活动性 UC 中,微生物多样性的减少越来越受到关注。通过饮食干预、益生元和益生菌化合物以及粪便微生物群移植来操纵肠道微生物群可能会扩大 UC 的治疗领域。特定的饮食,如地中海饮食或富含欧米伽-3 脂肪酸的饮食,可能会减轻肠道炎症,或者可能降低 UC 发病的风险。这篇综述总结了我们对 UC 和袋炎的肠道微生物群治疗的认识。